Generic Drug Makers Had No Duty to Send ‘Dear Doctor’ Letter, Pa. Court Affirms



DOCUMENTS
  • Opinion


PHILADELPHIA — Two generic Reglan manufacturers had no duty to send a prescribing doctor a “Dear Health Care Provider” letter regarding updates to the drug’s warning label, a Pennsylvania appellate court has ruled, because they had already satisfied their duty to warn by including adequate warnings in the drug’s packaging.

In an Dec. 1 opinion, the Pennsylvania Superior Court rejected plaintiffs’ argument that the drug makers’ failure to send such a letter fell short of Pennsylvania law requiring drug manufacturers to provide warnings and related prescribing information to physicians.

“Pennsylvania law does not impose on drug manufacturers a duty to …






UPCOMING CONFERENCES




HarrisMartin's Webinar Series: New Jersey Asbestos Litigation

February 11, 2021 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS



HarrisMartin's Webinar Series: Benzene Litigation - Using Genomics in the Courtroom

February 18, 2021 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS